Next Generation Sequencing (NGS) Service - Market: Size, Share, Growth, Analysis, Key Players, Revenue, | Valuates Reports

Next Generation Sequencing (NGS) Service - Market Size
The global market for Next Generation Sequencing (NGS) Service was estimated to be worth US$ 4628.2 million in 2023 and is forecast to a readjusted size of US$ 15180 million by 2030 with a CAGR of 17.3% during the forecast period 2024-2030
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-7P14103/Global_Next_Generation_Sequencing_NGS_Service_Market_Research_Report_2023

Next Generation Sequencing (NGS) Service - Market
Next Generation Sequencing (NGS) Service is a high-throughput sequencing technology that can quickly and efficiently sequence large amounts of DNA or RNA samples. This kind of service is widely used in genetic disease research, HLA typing, cancer research, infectious disease research and other fields.
The Rise of Personalized Medicine: With advances in genomics and precision medicine, more patients and healthcare providers are beginning to realize the potential of personalized medicine. NGS services can be used for genetic testing and disease prediction, and can provide patients with personalized treatment plans, helping to improve treatment effects and patients' quality of life.
Integration of big data and artificial intelligence: The amount of data generated by NGS is huge. Through big data analysis and artificial intelligence technology, these data can be better analyzed to provide more accurate diagnostic results and more effective treatment suggestions. Artificial intelligence can also help analyze complex data sets and improve the accuracy and reliability of NGS services.
Development of telemedicine services: With the development of Internet and mobile communication technology, telemedicine services are gradually emerging. NGS services can be provided remotely. Patients can perform genetic testing at home, and doctors can analyze the results and provide treatment plans remotely. This provides patients with convenient and fast services and provides doctors with a broader range of services.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Next Generation Sequencing (NGS) Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Next Generation Sequencing (NGS) Service by region & country, by Type, and by Application.
The Next Generation Sequencing (NGS) Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation Sequencing (NGS) Service.

Get regional report
https://reports.valuates.com/request/regional/QYRE-Auto-7P14103/Global_Next_Generation_Sequencing_NGS_Service_Market_Research_Report_2023

Segment by Type:
• Targeted Sequencing & Resequencing
• Whole Genome Sequencing
• Whole Exome Sequencing

Segment by Application

• Whole-genome Sequencing
• Exome Sequencing
• Targeted Resequencing
• De Novo Sequencing
• RNA Sequencing
• ChIP Sequencing
• Methyl Sequencing
• Others

By Company

454 Life Sciences Corporation (Roche), Agilent Technologies, Biomatters, Ltd, CLC Bio, GATC biotech AG, Macrogen, BGI (Beijing Genomics Institute), Illumina, Life Technology Corporation, EMC Corporation, Dnastar

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-7P14103/next-generation-sequencing-ngs-service-global

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.